DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
23 sep 2010 - 07:31
Statutaire naam
DSM B.V.
Titel
DSM finalizes portfolio transformation and enters era of focused growth
Bericht
Vision 2010 strategic targets mostly achieved despite economic downturn
Portfolio transformation to Life Sciences and Materials Sciences finalized,
DSM will now drive focused growth
Ambitious profitability targets set: EBITDA € 1.4-1.6 bn; ROCE >15% by 2013
Sales from High Growth Economies to increase towards 50% of total sales by 2015; target to double China sales to over $ 3 bn
Sales from Innovation to increase further from ~12% of total sales in 2010 to 20% by 2015
Sustainability: from responsibility to business driver; 80% of innovation pipeline to be ECO+ products
Organic sales growth of 5-7% to be enhanced with Acquisitions & Partnerships
DSM will adjust its organization to become truly global
Next step in dividend development: € 0.10 increase to € 1.30 per ordinary share announced
Outlook for 2010 confirmed
Gerelateerde downloads
Datum laatste update: 28 juli 2024